Evidence map›Paper›PMID 26479438›Full record

ArticleNature chemical biology2015

MicroRNAs regulate the immunometabolic response to viral infection in the liver.

Ragunath Singaravelu, Shifawn O'Hara, Daniel M Jones, Ran Chen, Nathan G Taylor, Prashanth Srinivasan, Curtis Quan, Dominic G Roy, Rineke H Steenbergen, Anil Kumar and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Ragunath SingaraveluDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.ORCID http://orcid.org/0000-0002-2692-3650
Shifawn O'HaraLife Sciences Division, National Research Council of Canada, Ottawa, Ontario, Canada.
Daniel M JonesImmunology and Infectious Diseases, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
Ran ChenDepartment of Medical Microbiology and Immunology, University of Alberta and Li Ka Shing Institute of Virology, Katz Centre for Pharmacy and Health Research, Edmonton, Alberta, Canada.
Nathan G TaylorImmunology and Infectious Diseases, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
Prashanth SrinivasanDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
Curtis QuanDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
Dominic G RoyCenter for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Rineke H SteenbergenDepartment of Medical Microbiology and Immunology, University of Alberta and Li Ka Shing Institute of Virology, Katz Centre for Pharmacy and Health Research, Edmonton, Alberta, Canada.
Anil KumarDepartment of Cell Biology, University of Alberta, Edmonton, Alberta, Canada.
Rodney K LynLife Sciences Division, National Research Council of Canada, Ottawa, Ontario, Canada.
Dennis ÖzcelikLife Sciences Division, National Research Council of Canada, Ottawa, Ontario, Canada.
Yanouchka RouleauLife Sciences Division, National Research Council of Canada, Ottawa, Ontario, Canada.
My-Anh NguyenDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
Katey J RaynerDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
Tom C HobmanDepartment of Cell Biology, University of Alberta, Edmonton, Alberta, Canada.
David Lorne TyrrellDepartment of Medical Microbiology and Immunology, University of Alberta and Li Ka Shing Institute of Virology, Katz Centre for Pharmacy and Health Research, Edmonton, Alberta, Canada.
Rodney S RussellImmunology and Infectious Diseases, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.ORCID http://orcid.org/0000-0002-0051-746X
John Paul PezackiDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
University of Ottawa · CAUniversity of Alberta · CAMemorial University of Newfoundland · CANational Research Council Canada · CAOttawa Hospital · CA

Funding

Canadian Institutes of Health Research 136807Canadian Institutes of Health Research 232063
6 · The paper itself

Abstract

Immune regulation of cellular metabolism can be responsible for successful responses to invading pathogens. Viruses alter their hosts' cellular metabolism to facilitate infection. Conversely, the innate antiviral responses of mammalian cells target these metabolic pathways to restrict viral propagation. We identified miR-130b and miR-185 as hepatic microRNAs (miRNAs) whose expression is stimulated by 25-hydroxycholesterol (25-HC), an antiviral oxysterol secreted by interferon-stimulated macrophages and dendritic cells, during hepatitis C virus (HCV) infection. However, 25-HC only directly stimulated miR-185 expression, whereas HCV regulated miR-130b expression. Independently, miR-130b and miR-185 inhibited HCV infection. In particular, miR-185 significantly restricted host metabolic pathways crucial to the HCV life cycle. Interestingly, HCV infection decreased miR-185 and miR-130b levels to promote lipid accumulation and counteract 25-HC's antiviral effect. Furthermore, miR-185 can inhibit other viruses through the regulation of immunometabolic pathways. These data establish these microRNAs as a key link between innate defenses and metabolism in the liver.

Indexed as

Antiviral AgentsCell LineHepacivirusHepatitis CHumansHydroxycholesterolsLiverMicroRNAsMolecular Conformation25-hydroxycholesterolAntiviral AgentsHydroxycholesterolsMicroRNAs

Identifiers

PMID26479438
OpenAlexW2189900886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.